Travere Therapeutics, Inc. (TVTX)
34.83
-0.18
(-0.51%)
USD |
NASDAQ |
Dec 12, 16:00
34.83
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Free Cash Flow: -107.47M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Iovance Biotherapeutics, Inc. | -351.82M |
| Xenetic Biosciences, Inc. | -2.718M |
| KalVista Pharmaceuticals, Inc. | -- |
| BeyondSpring, Inc. | -- |
| Solid Biosciences, Inc. | -133.17M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 14.32M |
| Cash from Investing (Quarterly) | 86.59M |
| Cash from Financing (Quarterly) | -65.34M |
| Free Cash Flow Per Share (Quarterly) | -0.0085 |
| Free Cash Flow to Equity (Quarterly) | 68.95M |
| Free Cash Flow to Firm (Quarterly) | 1.879M |
| Free Cash Flow Yield | -3.40% |